Matrix Metalloproteinase 16 [matrixová metaloproteinasa 16]
- Terms
-
matrix metaloproteináza 16
matrixová metaloproteináza 16
matrixová metaloproteináza membránového typu 3
metaloproteinasa MMP-16
metaloproteinasa MMP16
metaloproteináza MMP-16
metaloproteináza MMP16
MT3-MMP
protein MMP-X2
-
Membrane-Type 3 Matrix Metalloproteinase
Membrane-Type Matrix Metalloproteinase 3
Membrane-Type-3 Matrix Metalloproteinase
MMP-16 Metalloproteinase
MMP-X2 Protein
MMP16 Metalloproteinase
MT3-Matrix Metalloproteinase
MT3-MMP
A transmembrane domain-containing matrix metalloproteinase. It is synthesized as an inactive zymogen that is activated by the proteolytic action of PROPROTEIN CONVERTASES. Matrix metalloproteinase 16 plays a direct role in the cleavage of proteins in the pericellular environment. In addition, it can function indirectly by enzymatically activating the proprotein form of other MATRIX METALLOPROTEINASES such as the zymogen of MATRIX METALLOPROTEINASE 2.
- DUI
- D053513 MeSH Browser
- CUI
- M0284099
- History note
- 2007(2005)
- Public note
- 2007; MATRIX METALLOPROTEINASE 16 was indexed under MATRIX METALLOPROTEINASES 2006 & under METALLOENDOPEPTIDASES 2005
Combination
- antagonists & inhibitors
- Matrix Metalloproteinase Inhibitors
Allowable subheadings
- AD
- administration & dosage 0
- AE
- adverse effects 0
- AN
- analysis 0
- BI
- biosynthesis 0
- BL
- blood 0
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 0
- CL
- classification 0
- DF
- deficiency 0
- DE
- drug effects 0
- EC
- economics 0
- GE
- genetics 0
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 0
- ME
- metabolism 0
- PK
- pharmacokinetics 0
- PD
- pharmacology 0
- PH
- physiology 0
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 0
- TO
- toxicity 0
- UL
- ultrastructure 0
- UR
- urine 0